NCT06791629View on ClinicalTrials.gov

Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation

NANot yet recruitingINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

February 15, 2025

Primary Completion Date

December 15, 2026

Study Completion Date

February 15, 2027

Conditions
Persistent Atrial FibrillationRadiofrequency Catheter AblationPulsed Field Ablation
Interventions
DEVICE

Pulsed Field Ablation

Patients will be treated with pulsed field ablation for atrial fibrillation.

DEVICE

Radiofrequency Ablation

Patients will be treated with radiofrequency ablation for atrial fibrillation.

Trial Locations (1)

Unknown

Beijing Anzhen Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Anzhen Hospital

OTHER

NCT06791629 - Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation | Biotech Hunter | Biotech Hunter